New from ASHG

Thermo Fisher virtually presented at the American Society on Human Genetics (Oct 27-30). These presentations are of particular interest around the theme of "Predictive Genomics: It's time to re-imagine healthcare together".

Discoveries and translational opportunities arising from the FinnGen Project
Aarno Palotie, M.D., Ph.D. and Samuli Ripatti, Ph.D.
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland Broad Institute of MIT and Harvard, MA, US

The Taiwan Precision Medicine Initiative: Incorporating Genetics In Clinical Practice
Pui Yan Kwok, M.D., Ph.D.
Henry Bachrach Distinguished Professor at UCSF and Director of the Institute of Biomedical Sciences at the Academia Sinica in Taiwan

MADCaP: The First Large Pan-African GWAS Tackling Cancer Health Disparities in African Populations
Timothy Rebbeck, PhD
Vincent L. Gregory, Jr. Professor of Cancer Prevention, Harvard TH Chan School of Public Health and Division of Population Sciences, Dana Farber Cancer Institute

How comprehensive pharmacogenomics accelerates personalized therapies and reduces health disparities for minorities
Dr. Ulrich Broeckel, MD Founder and CEO, RPRD Diagnostics

Preemptive PGx at population-scale: Implementation in Pittsburgh
Philip Empey, PharmD, PhD, Assoc. Director, Institute for Precision Medicine
Assoc Professor, Pharmacy & Therapeutics

Implementing a world-class clinical pharmacogenomics service
Dr. Hyun Kim, Clinical Pharmacist, Clinical Pharmacogenomics Service, Boston Children's Hospital

Polygenic Risk Scores - Value & Path into the Clinic

Sir Peter Donnelly (Founder, Genomic plc) & Dr. Jill Hagenkord (VP Genomics, Optum) share the stage in a presentation and panel discussion on incorporating polygenic risk scores and application in the clinic